NewAmsterdam Pharma (NAMS) Earnings Date & Reports

Get AI intraday signals

A.I. Advisor

published Earnings

NAMS is expected to report earnings to rise 187.67% to -51 cents per share on March 28

NewAmsterdam Pharma NAMS Stock Earnings Reports

Q4'24

Est.

$-0.52

Q3'24

Beat

by $0.32

Q2'24

Beat

by $0.17

Q1'24

Missed

by $0.44

Q4'23

Beat

by $0.04

The last earnings report on November 06 showed earnings per share of -18 cents, beating the estimate of -49 cents. With 637.19K shares outstanding, the current market capitalization sits at 2.85B.

View a ticker or compare two or three

Compare

NAMS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For NAMS
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for NAMS (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

Gooimeer 2-35

Phone

+31 352062971

Employees

Web

https://www.newamsterdampharma.com